Stem Cells & Regenerative Medicine Congress USA

INNOVATION.COLLABORATION.
COMMERCIALIZATION.

Where stem cell, regenerative medicine, cell & gene therapy biotechs gather, discussing strategies to develop & commercialize the next gen cure for unmet needs  

 

Welcome to the Regenerative Renaissance

 

Since 1961, when the existence of Stem Cells was proven accidentally, regenerative medicine has bloomed, shrunk, contracted, been hated and misunderstood all at once. 

In 2008, the Stem Cells and Regenerative Medicine Congress had its inaugural year in the United States. Combined with President Obama’s promise to move the regenerative medicine industry forward, the event has grown year after year to become the premier event for those active in this space. 

At this year’s event the regenerative medicine industry is taking it to the next level and discussing how genomics is changing the field – and highlighting the commercialization and manufacturing stories that have helped spur the recent success. 

Discover the future of the regenerative medicine industry with exclusive content.

AGENDA PREVIEW AVAILABLE HERE

 

 

Meet the experts

 

Regenerative medicine isn’t just a story about science, it is a story about people. That story is just starting to get good. Personalized medicine? Regenerative medicine has been doing it for years. It’s about time the rest of the industry caught up.

 

 

  • Dr Rahul Aras at Stem Cells & Regenerative Medicine Congress USA
    Dr Rahul Aras
    Chief Executive Officer
    Juventas Therapeutics
    Mr Kurtis Bachman at Stem Cells & Regenerative Medicine Congress USA
    Mr Kurtis Bachman
    US Head, Computational and Systems Biology
    Janssen
  • Dr Gil Van Bokkelen at Stem Cells & Regenerative Medicine Congress USA
    Dr Gil Van Bokkelen
    Chairman and Chief Executive Officer
    Athersys, Inc.
    Dr Eric David at Stem Cells & Regenerative Medicine Congress USA
    Dr Eric David
    Chief Medical Officer
    Organovo
  • Luca Gattinoni at Stem Cells & Regenerative Medicine Congress USA
    Luca Gattinoni
    Investigator Experimental Transplantation and Immunology Branch
    National Institutes of Health
    Mr Robert Hariri at Stem Cells & Regenerative Medicine Congress USA
    Mr Robert Hariri
    Chairman and Founder for Cellular Therapeutics Division
    Celgene Corporation
  • Dr Hans Klingemann at Stem Cells & Regenerative Medicine Congress USA
    Dr Hans Klingemann
    CMO & CSO
    Conkwest Inc
    Ms Mary Laughlin at Stem Cells & Regenerative Medicine Congress USA
    Ms Mary Laughlin
    Global Program Medical Director
    Novartis Pharmaceuticals
  • Antonio Lee, Ph.D. at Stem Cells & Regenerative Medicine Congress USA
    Antonio Lee, Ph.D.
    Chief Executive Officer & Managing Director
    MEDIPOST America, Inc.
    Shelley Nelson at Stem Cells & Regenerative Medicine Congress USA
    Shelley Nelson
    regulatory professional
    Janssen R
  • Daniel Orlando at Stem Cells & Regenerative Medicine Congress USA
    Daniel Orlando
    Chief Operating Officer
    Vericel Corporation
    Mr Hans Preusting at Stem Cells & Regenerative Medicine Congress USA
    Mr Hans Preusting
    Business Development, Vice President
    Uniqure Bv
  • Mr Brock Reeve at Stem Cells & Regenerative Medicine Congress USA
    Mr Brock Reeve
    Executive Director
    Harvard Stem Cell Institute
    Mr Christopher Reinhard at Stem Cells & Regenerative Medicine Congress USA
    Mr Christopher Reinhard
    Chief Executive Officer
    Cardium Therapeutics Inc
  • Cynthia Sherman at Stem Cells & Regenerative Medicine Congress USA
    Cynthia Sherman
    Senior Director, Health Policy
    Osiris Therapeutics, Inc
    Dr Timothy Smith at Stem Cells & Regenerative Medicine Congress USA
    Dr Timothy Smith
    Chief Executive Officer
    Octane Biotech
  • Mr Devyn Smith at Stem Cells & Regenerative Medicine Congress USA
    Mr Devyn Smith
    Senior Director Strategic Management Group
    Pfizer Global Research and Development
    Dr Ann Tsukamoto at Stem Cells & Regenerative Medicine Congress USA
    Dr Ann Tsukamoto
    Executive Vice President of Research and Development
    Stemcells Inc
  • Michael D West at Stem Cells & Regenerative Medicine Congress USA
    Michael D West
    Chief Executive Officer and Director
    BioTime , Inc.

 

 

 

Meet key industry leaders 

 

 

Join 300+ attendees from stem cell, regenerative medicine, cell & gene therapy biotechs 

Discuss the hottest industry topics and make new connections

Hear from 70+ speakers

Learn from the best and brightest in the industry.

Take advantage of 13+ hours of networking

With networking drinks receptions, 1-2-1 partnering, a networking app and speed networking... we've got it all! Take part in a variety of formal and informal opportunities.

 

SPONSORSHIP PROSPECTUS

 

 

Position yourself as an industry leader

Contact us today to secure your position as a partner, sponsor or exhibitor at the show.

It's more than great content

This event is an opportunity to showcase your services to your target market. By sponsoring our event, you can  develop relationships, make sales and raise your company's profile.

Lead Generation Programme

Sponsoring involves more than just a two day event. We have access to the Total BioPharma community of almost 250,000 people. You provide us with great content, and we'll distribute it through email, our blog and multiple social media channels.

1-2-1 Partnering

Your success at the show is dependent on the quality relationships you build. Take a look at the delegate list before the event, decide who you want to meet and we'll make it happen.

 

SPONSORSHIP PROSPECTUS

Our Sponsors


  • Gold Sponsor

    Octane Medical Group at Stem Cells & Regenerative Medicine Congress USA
  • Exhibitor

    WuXi AppTec, Inc at Stem Cells & Regenerative Medicine Congress USA
  • Exhibitor

    Beckman Coulter at Stem Cells & Regenerative Medicine Congress USA
  • Exhibitor

    SynGen Inc at Stem Cells & Regenerative Medicine Congress USA
  • Exhibitor

    American Fluoroseal Corp Part of Saint Gobain Performance Plastics at Stem Cells & Regenerative Medicine Congress USA

SEE OUR SPONSORS

 

New uses for Cord Blood as an immunotherapy - will be covered at the Cord Blood World Europe Congress, 20-21 May in London at the Business Design Centre

New uses for Cord Blood as an immunotherapy and in the treatment of lysosomal storage disease

Dr Jaap Boelens, Pediatric Oncologist at the University of Utrecht has also been working on developing multiple treatments using cord blood. One of which involves ...

The post New uses for Cord Blood as an immunotherapy and in the treatment of lysosomal storage disease appeared first on Total Biopharma.

World Stem Cells & Regenerative Medicine Congress 2015

NEW Leading industry insights from stem cells & regenerative medicine professionals

In 3 weeks, London will welcome over 80 leading international speakers to the 10th annual World Stem Cells & Regenerative Medicine Congress. Ahead of then ...

The post NEW Leading industry insights from stem cells & regenerative medicine professionals appeared first on Total Biopharma.

366 logo

Press release: World Drug Safety Conference hears call for wider use of cognitive safety testing in drug development

April 30, 2015 In a call to the pharmaceutical industry at the World Drug Safety Conference in Chicago last week (April 22 to 23), a ...

The post Press release: World Drug Safety Conference hears call for wider use of cognitive safety testing in drug development appeared first on Total Biopharma.

Join the Community

Innovation and strategy for pharmaceutical, biotech and R&D

Sign Up to Our Newsletter